Similar articles

• Younger age of escalation of cardiovascular risk factors in Asian Indian subjects.

  Gupta R, Misra A, Vikram NK, Kondal D, Gupta SS, Agrawal A, Pandey RM. Gupta R, et al. BMC Cardiovasc Disord. 2009 Jul 5;9:28. doi: 10.1186/1471-2261-9-28. BMC Cardiovasc Disord. 2009. PMID: 19575817 Free PMC article.
• Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study.

  Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A. Higashiyama A, et al. Circ J. 2009 Dec;73(12):2258-63. doi: 10.1253/circj.cj-09-0264. Epub 2009 Oct 17. Circ J. 2009. PMID: 19838005
• Alcohol, smoking, and obesity epidemiology in Japan.

  Tsugane S. Tsugane S. J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:121-6. doi: 10.1111/j.1440-1746.2011.07021.x. J Gastroenterol Hepatol. 2012. PMID: 22320929
• Evolving cardiovascular disease prevalence, mortality, risk factors, and the metabolic syndrome in China.

  Zheng Y, Stein R, Kwan T, Yu C, Kwan J, Chen SL, Hu D. Zheng Y, et al. Clin Cardiol. 2009 Sep;32(9):491-7. doi: 10.1002/clc.20605. Clin Cardiol. 2009. PMID: 19743493 Free PMC article. Review.
• Dyslipidaemia, hypercoagulability and the metabolic syndrome.

  Kakafika AI, Liberopoulos EN, Karagiannis A, Athyros VG, Mikhailidis DP. Kakafika AI, et al. Curr Vasc Pharmacol. 2006 Jul;4(3):175-83. doi: 10.2174/157016106777698432. Curr Vasc Pharmacol. 2006. PMID: 16842135 Review.